Metformin Plus Insulin Therapy Does Not Reduce Neonatal Adverse Outcomes
Metformin plus insulin therapy vs placebo was not associated with reduced neonatal adverse outcomes among type 2 and gestational diabetes patients.
United States Journal Of The American Medical Association American Medical Medical Optimization Overt Type
Source: endocrinologyadvisor.com